UroGen Pharma
URGN
$13.22
Share price
0.08%
Change (1 day)
11.09%
Change (1 year)
Categories
UroGen Pharma (URGN) - P/B ratio
P/B ratio as of May 2024 : -7.32
According to UroGen Pharma's latest financial reports the company has a price-to-book ratio of -7.32.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
UroGen Pharma - P/B ratio (from 2017 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -7.10 | 209.78% |
| 2022-12-31 | -2.29 | -109.03% |
| 2021-12-31 | 25.4 | 512.48% |
| 2020-12-31 | 4.15 | 6.53% |
| 2019-12-31 | 3.89 | -49.79% |
| 2018-12-31 | 7.75 | 8.28% |
| 2017-12-31 | 7.16 | |
| 2016-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.71 | -137.08% | 🇺🇸 USA |